Copernicus Therapeutics

Copernicus Therapeutics, Inc. (CTI) operates as a biopharmaceutical company in the clinical stage, focusing specifically on the utilization of gene therapy to address diseases with substantial unmet need. The team comprises a diverse range of medical professionals, researchers, and patient champions committed to leveraging their expertise and insights to develop innovative treatments that enhance quality of life. Founded on advancements originating from Case Western Reserve University in Cleveland, Ohio, the company has a strong affiliation with the burgeoning biotechnology sector in Northeast Ohio.